Voors AA - Search Results

1

β₁-Adrenoreceptor Autoantibodies in Heart Failure: Physiology and Therapeutic Implications.

Düngen HD, Dordevic A, Felix SB, Pieske B, Voors AA, McMurray JJV, Butler J. Düngen HD, et al. Among authors: voors aa. Circ Heart Fail. 2020 Jan;13(1):e006155. doi: 10.1161/CIRCHEARTFAILURE.119.006155. Epub 2020 Jan 20. Circ Heart Fail. 2020. PMID: 31957469 Review.

2

Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure.

Voors AA, Petrie CJ, Petrie MC, Charlesworth A, Hillege HL, Zijlstra F, McMurray JJ, van Veldhuisen DJ. Voors AA, et al. Eur Heart J. 2005 Sep;26(17):1759-64. doi: 10.1093/eurheartj/ehi270. Epub 2005 Apr 15. Eur Heart J. 2005. PMID: 15833758

3

The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy.

van der Meer P, De Boer RA, White HL, van der Steege G, Hall AS, Voors AA, van Veldhuisen DJ. van der Meer P, et al. Among authors: voors aa. J Card Fail. 2005 May;11(4):279-84. doi: 10.1016/j.cardfail.2004.11.006. J Card Fail. 2005. PMID: 15880336 Clinical Trial.

4

Erythropoietin in chronic heart failure.

Belonje AM, Voors AA, van Gilst WH, van Veldhuisen DJ. Belonje AM, et al. Among authors: voors aa. Congest Heart Fail. 2007 Sep-Oct;13(5):289-92. doi: 10.1111/j.1527-5299.2007.06662.x. Congest Heart Fail. 2007. PMID: 17917496 Free article. Review.

5

beta-Adrenoceptor antagonists in elderly patients with heart failure: a critical review of their efficacy and tolerability.

Dobre D, Haaijer-Ruskamp FM, Voors AA, van Veldhuisen DJ. Dobre D, et al. Among authors: voors aa. Drugs Aging. 2007;24(12):1031-44. doi: 10.2165/00002512-200724120-00006. Drugs Aging. 2007. PMID: 18020535 Review.

6

Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications.

Hartog JW, Voors AA, Bakker SJ, Smit AJ, van Veldhuisen DJ. Hartog JW, et al. Among authors: voors aa. Eur J Heart Fail. 2007 Dec;9(12):1146-55. doi: 10.1016/j.ejheart.2007.09.009. Eur J Heart Fail. 2007. PMID: 18023248 Free article. Review.

7

Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit.

Lipsic E, Westenbrink BD, van der Meer P, van der Harst P, Voors AA, van Veldhuisen DJ, Schoemaker RG, van Gilst WH. Lipsic E, et al. Among authors: voors aa. Eur J Heart Fail. 2008 Jan;10(1):22-9. doi: 10.1016/j.ejheart.2007.10.008. Eur J Heart Fail. 2008. PMID: 18077209 Free article.

8

Overview of emerging pharmacologic agents for acute heart failure syndromes.

De Luca L, Mebazaa A, Filippatos G, Parissis JT, Böhm M, Voors AA, Nieminen M, Zannad F, Rhodes A, El-Banayosy A, Dickstein K, Gheorghiade M. De Luca L, et al. Among authors: voors aa. Eur J Heart Fail. 2008 Feb;10(2):201-13. doi: 10.1016/j.ejheart.2008.01.002. Eur J Heart Fail. 2008. PMID: 18279775 Free article. Review.

9

Urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure.

Linssen GC, Damman K, Hillege HL, Navis G, van Veldhuisen DJ, Voors AA. Linssen GC, et al. Among authors: voors aa. Circulation. 2009 Jul 7;120(1):35-41. doi: 10.1161/CIRCULATIONAHA.108.824581. Epub 2009 Jun 22. Circulation. 2009. PMID: 19546389

10

Endogenous erythropoietin and outcome in heart failure.

Belonje AM, Voors AA, van der Meer P, van Gilst WH, Jaarsma T, van Veldhuisen DJ. Belonje AM, et al. Among authors: voors aa. Circulation. 2010 Jan 19;121(2):245-51. doi: 10.1161/CIRCULATIONAHA.108.844662. Epub 2010 Jan 4. Circulation. 2010. PMID: 20048213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

753 results

Search Page